Lipid-lowering therapies in development. - Wikidata - wikimedia - TriplyDB

Lipid-lowering therapies in development.

Lipid-lowering therapies in development.

http://www.wikidata.org/entity/Q35925570

about

Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases.Antisense oligonucleotides as therapeutics for hyperlipidaemias.

P2860

Q35099028-1F8BF66C-386F-4EC5-B79D-D9B6F3C2E02B Q36194069-49B1640D-7D46-4494-AA16-B94BB49D8A64

P2860

Lipid-lowering therapies in development.

http://www.wikidata.org/entity/Q35925570

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Lipid-lowering therapies in development.

@ast

Lipid-lowering therapies in development.

@en

type

label

Lipid-lowering therapies in development.

@ast

Lipid-lowering therapies in development.

@en

prefLabel

Lipid-lowering therapies in development.

@ast

Lipid-lowering therapies in development.

@en

P1433

Q35925570-F1CB8D29-582A-4E96-BCF6-19F7C06FD83D

P1476

Q35925570-7852CCCF-7141-4F07-A84E-4D40485E22C2

P2860

Q35925570-0B0F9D85-7B04-437E-B71A-E1AD4931E852

Q35925570-0FD8E0F2-96BA-4756-9554-F1E04B214AE7

Q35925570-124A76D4-CB13-4430-9628-F37D1F9818E9

Q35925570-1BB7EAF8-02D4-4497-AF0D-BD01D2999342

Q35925570-1C61BDC3-3589-4583-A4AA-C9C8DC44B406

Q35925570-20498F69-ED32-4D1A-87A9-8C9B417550C6

Q35925570-225184B5-9BE5-4603-B727-AF2A6F94A48A

Q35925570-2366A7EE-D23A-4FF3-A113-1C8C55CC75A2

Q35925570-34FB9007-C882-44BA-BEBB-B6E1FB2460B9

Q35925570-356D854E-7484-48C5-8520-E8D08B6F9470

P304

Q35925570-0E147F4F-D3A0-460D-A3CD-AA033027E941

P31

Q35925570-F6CB926C-F1D6-4FEF-8D8C-6A1BA5FA56C7

P356

Q35925570-FC341CEE-2104-43D9-90B3-D136D90A8A2B

P407

Q35925570-1C20C7CC-307A-45FA-A220-2F7DE677F4F8

P433

Q35925570-B8AC6488-04A6-41CF-8118-7726AAD0E696

P478

Q35925570-4DB2E562-22DF-4F59-84A1-EC01D46C6F32

P50

Q35925570-CD857E7E-B7CA-4005-8C70-23913F6136BF

P577

Q35925570-F0D9D888-D8E8-41B4-90FE-17D3038AAC4F

P698

Q35925570-49885681-EA64-411E-BD7A-086F37AFF8B0

P356

13543784.13.11.1405

P1433

Expert Opinion on Investigational Drugs

P1476

Lipid-lowering therapies in development.

@en

P2860

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase

A strategy to reduce cardiovascular disease by more than 80%

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Statin-fibrate combination: therapy for hyperlipidemia: a review

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Apolipoprotein A-I(Milano): current perspectives

Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

P304

1405-1418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.11.1405

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Anthony S Wierzbicki

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500389

http://www.w3.org/2001/XMLSchema#string